PCa At End of Biopsy Core A Bad Sign

DENVER—The presence of tumor cells at the end of a needle biopsy core obtained near the capsule is an independent indicator of a significantly elevated risk of extracapsular extension, according to data presented here at the annual meeting of the United States and Canada Academy of Pathology.

Sextant Biopsy Alone May Miss Tumors

Prostate biopsies in men with a PSA level of 4.01-10.0 ng/mL and normal findings on digital rectal examination (DRE) should include lateral cores in addition to the sextant biopsy, according to investigators.

Testis Biopsy for Sperm is Unreliable

WASHINGTON, D.C.—Diagnostic testis biopsies in men with non-obstructive azoospermia (NOA) will not provide definitive proof as to whether sperm will be found with a more intensive evaluation of the testes, according to researchers at New York-Presbyterian Hospital-Weill Cornell Medical Center in New York.

Post-Biopsy Prophylaxis Caution Urged

SAN DIEGO—Urologists may need to re-examine the use of oral fluoroquinolones (FQ) as prophylaxis after transrectal ultrasound-guided (TRUS) biopsy of the prostate, according to study findings presented here at the annual meeting of the Infectious Diseases Society of America.

Ointment Eases Prostate Biopsy Pain

Topical glyceryl trinitrate (GTN) ointment is safe and effective in decreasing discomfort associated with transrectal ultrasonography (TRUS)-guided biopsy of the prostate, researchers conclude.

Next post in News